Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu,
No information about this author
Yifan Li,
No information about this author
Zhaolan Feng
No information about this author
et al.
Cells,
Journal Year:
2025,
Volume and Issue:
14(3), P. 221 - 221
Published: Feb. 4, 2025
Cigarette
smoke
(CS),
an
intricate
blend
comprising
over
4000
compounds,
induces
abnormal
cellular
reactions
that
harm
multiple
tissues.
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
prevalent
chronic
(CLD),
encompassing
non-alcoholic
(NAFL),
steatohepatitis
(NASH),
cirrhosis,
and
hepatocellular
carcinoma
(HCC).
Recently,
the
term
NAFLD
has
been
changed
to
metabolic
dysfunction-associated
steatotic
(MASLD),
NASH
renamed
(MASH).
A
multitude
of
experiments
have
confirmed
association
between
CS
incidence
progression
MASLD.
However,
specific
signaling
pathways
involved
need
be
updated
with
new
scientific
discoveries.
exposure
can
disrupt
lipid
metabolism,
induce
inflammation
apoptosis,
stimulate
fibrosis
through
promote
Currently,
there
no
officially
approved
efficacious
pharmaceutical
intervention
in
clinical
practice.
Therefore,
lifestyle
modifications
emerged
as
primary
therapeutic
approach
for
managing
Smoking
cessation
application
series
natural
ingredients
shown
ameliorate
pathological
changes
induced
by
CS,
potentially
serving
effective
decelerating
MASLD
development.
This
article
aims
elucidate
which
smoking
promotes
MASLD,
while
summarizing
reversal
factors
identified
recent
studies,
thereby
offering
novel
insights
future
research
on
treatment
Language: Английский
Impact of healthy lifestyles on the risk of metabolic dysfunction‐associated steatotic liver disease among adults with comorbid hypertension and diabetes: Novel insight from a largely middle‐aged and elderly cohort in South China
Diabetes Obesity and Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 7, 2025
The
association
between
lifestyle
and
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
has
been
well
documented.
However,
evidence
is
still
limited
from
vulnerable
populations,
especially
middle-aged
elderly
adults
with
comorbid
hypertension
diabetes,
who
are
at
higher
risk
of
developing
MASLD
than
the
general
population.
We
aimed
to
examine
potential
causal
links
a
healthy
in
this
A
total
41,964
participants
diabetes
were
included
longitudinal
cohort
2010
2023.
Weighted
scores
for
evaluated
by
exercise
frequency,
alcohol
consumption,
smoking
status
salt
intake.
Marginal
structural
models
used
estimate
single
lifestyle-MASLD
associations,
which
further
stratified
quartile
ranges
weighted
scores.
mean
follow-up
period
5.2
years
(217
972
person-years)
revealed
that
21
697
developed
MASLD.
hazard
ratio
(HR)
daily
exercise,
never
consuming
alcohol,
low
intake
was
0.617
(95%
confidence
interval:
0.365
~
1.042),
0.237
(0.093
0.603),
0.153
(0.097
0.240)
0.945
(0.919
0.971),
respectively.
Compared
below
25th
percentile,
HR
0.952
(0.902
1.005),
0.747
(0.694
0.803)
0.097
(0.065
0.144)
25th,
50th
75th
percentiles,
In
population,
abstinence
low-salt
diet
may
reduce
MASLD,
most
stringent
combination
lifestyles
could
over
90%.
Language: Английский